Skip to main content
. 2018 Dec 12;18:94. doi: 10.1186/s12902-018-0322-7

Table 2.

Baseline characteristics

Baseline Characteristics
Pre-existing eye disease 11 (4 documented as mild/inactive)
Duration of Medical Treatment (months) 24 (3 weeks to 12 years)
Technetium uptake (%) 4.3 (0.8–66)
TSH receptor antibody (IU/L) 8 (0–240)
Smoker (documented) 15
Glucocorticoid cover with pre-existing eye disease 7

Data are expressed as median (range)